MDS Virtual Congress 2020 Archives - Page 138 of 149

The short- and long-term outcomes of STN DBS in PD patients with or without RBD

S.M Park, R. Kim, J.H Shin, H.J Kim, B.S Jeon (Seoul, Republic of Korea)
The sooner, the better: early diagnosis and treatment in functional neurological disorders

P. Parra-Díaz, J.L Chico García, E. Natera Villalba, V. Nedkova Hristova, F. Rodríguez Jorge, Á. Beltrán Corbellini, J.C Martínez Castrillo, J. Masjuan, A. Alonso Cánovas, I. Pareés Moreno (Madrid, Spain)
The study of the role of genetic risk factors in levodopa-induced dyskinesia development in Russian patients with Parkinson’s disease: a pilot study

G. Akhmadeeva, I. Khidiyatova, I. Gilyazova, A. Baitimerov, G. Tayupova, R. Magzhanov (Ufa, Russian Federation)
The Subthalamic Fasciculus and Connectivity Profiling of Stimulation-induced Dyskinesia following Pallidal DBS in Parkinson’s Disease

T. Tsuboi, A. Elkouzi, W. Deeb, A. Ramirez-Zamora, L. Almeida, P. Zeilman, R. Eisinger, K. Foote, L. Okromelidze, S. Grewal, M. Okun, E. Middlebrooks (Gainesville, FL, USA)
The Unique Voiceprint Changed In Parkinson’s Disease

F. XU (CHENGDU, China)
The UP study – Ursodeoxycholic acid (UDCA) as neuroprotective treatment for Parkinson’s disease

T. Payne, M. Appleby, E. Buckley, C. Mazza, T. Foltynie, O. Bandmann (Sheffield, United Kingdom)
The use of Virtual Reality to Assess the Quality of Life in Patients with Spinocerebellar Ataxia

B. Zeigelboim, B. Cavalcante-Leao, J.M Malisky, G.S Santos, M.S Severiani, H.T Teive (Curitiba, Brazil)
The usefulness of a dual-phase 18-F-FP-CIT PET in a case of Alzheimer’s disease with slow movement

WW. Lee (Seoul, Republic of Korea)
The utility of single dose levodopa challenges in the management of Parkinson’s disease

D. Tsui, D. Galea, N. Mahant, S. Kim, S. Babu, V. Fung (Sydney, Australia)
The variants of autophagy genes of early-onset Parkinson’s disease

H. Chang, E. Oh, J. Youn, J. Park, S. Kim, W. Jang (Daejeon, Republic of Korea)